CLINICAL TRIALS PROFILE FOR CHLORAMBUCIL
✉ Email this page to a colleague
All Clinical Trials for CHLORAMBUCIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003421 ↗ | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | Completed | Medical Research Council | Phase 3 | 1998-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for advanced Hodgkin's disease. PURPOSE: Randomized phase III trial to compare different combination chemotherapy regimens in treating patients with advanced Hodgkin's disease. |
| NCT00003617 ↗ | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | Unknown status | Lymphoma Trials Office | Phase 3 | 1995-03-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known whether chlorambucil is more effective than observation in treating low-grade lymphoma of the stomach. PURPOSE: Randomized phase III trial to compare the effectiveness of chlorambucil with that of no further therapy following anti-Helicobacter therapy in treating patients with low-grade lymphoma of the stomach. |
| NCT00003639 ↗ | Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | Unknown status | Scotland and Newcastle Lymphoma Group | Phase 3 | 1993-11-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Interferon alfa may interfere with the growth of cancer cells and slow the growth of non-Hodgkin's lymphoma. It is not yet known whether combining more than one chemotherapy drug with interferon alfa is more effective than chemotherapy alone in treating patients with low-grade non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without interferon alfa in treating patients with low-grade non-Hodgkin's lymphoma. |
| NCT00004218 ↗ | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | Completed | Medical Research Council | Phase 3 | 1999-10-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for chronic lymphocytic leukemia. PURPOSE: This randomized phase III trial is studying chlorambucil to see how well it works compared to fludarabine and cyclophosphamide or fludarabine alone in treating patients with newly diagnosed chronic lymphocytic leukemia. |
| NCT00004218 ↗ | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | Completed | Leukemia Research Fund | Phase 3 | 1999-10-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for chronic lymphocytic leukemia. PURPOSE: This randomized phase III trial is studying chlorambucil to see how well it works compared to fludarabine and cyclophosphamide or fludarabine alone in treating patients with newly diagnosed chronic lymphocytic leukemia. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHLORAMBUCIL
Condition Name
Clinical Trial Locations for CHLORAMBUCIL
Trials by Country
Clinical Trial Progress for CHLORAMBUCIL
Clinical Trial Phase
Clinical Trial Sponsors for CHLORAMBUCIL
Sponsor Name
